Mobile Menu

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us
  • Menu
  • Skip to primary navigation
  • Skip to main content

https://eyecro.com

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us

Preclinical Ophthalmic Contract Research

New Report from Prevent Blindness America Shows Sharp Increase in Eye Disease Prevalence

June 27, 2012 //  by stanselb

According to the 2012 update of the “Vision Problems in the U.S.” report, a study released today by Prevent Blindness America and the National Eye Institute, the number of those ages 40 and older with vision impairment and blindness has increased 23 percent since the year 2000.

In addition, a preliminary update to the 2007 Prevent Blindness America “Economic Impact of Vision Problems” report shows a $1 billion increase in costs of excess medical care expenditures, informal care and health-related quality of life related to visual impairment and blindness.

Statistics from the 2012 Vision Problems in the U.S. report on the four most common eye diseases highlight alarming increases since 2000, including:

  • 2,069,403 people age 50 and older have late AMD (age-related macular degeneration), a 25 percent increase
  • 24,409,978 million people age 40 and older have cataracts, a 19 percent increase
  • 2,719,379 million people age 40 and older have open-angle glaucoma, a 22 percent increase
  • 7,685,237 million people ages 40 and older have diabetic retinopathy, an 89 percent increase

To read the full report click here

Category: NewsTag: Age-related macular degeneration, AMD, cataracts, Diabetic retinopathy, glaucoma, National Eye Institute, Prevent Blindness America

Previous Post: « Nanotechnology-Based Cancer Treatment Can Reduce Side Effects
Next Post: Scientists See New Hope for Restoring Vision With Stem Cell Help »

© 2022 · EyeCRO · All Rights Reserved.